期刊文献+

临床药师干预前后围术期抗菌药物应用分析 被引量:13

Analysis of the Perioperative Use of Antibiotics before and after The Intervention by Clinical Pharmacists
下载PDF
导出
摘要 目的:了解临床药师干预围术期应用抗菌药物的效果,为合理用药提供参考。方法:我院临床药师于2011年5月与9月先后2次对围术期用药情况进行干预,以随机抽样法抽取每个季度手术患者病历50份,以《抗菌药物临床应用指导原则》为标准,对4个季度围术期抗菌药物使用情况进行统计分析与合理性评价。结果:经过干预,围术期抗菌药物的使用情况有了很大的进步,抗菌药物预防性使用率明显下降,不合理用药情况明显减少。结论:经过2次重点整治,我院围术期抗菌药物使用基本趋于合理,但尚需继续努力,将合理用药进一步规范化、制度化,进一步减轻患者负担,减少细菌耐药性的产生。 OBJECTIVE: To analyze the intervention efficacy of clinical pharmacists on perioperative use of antibiotics for reference of rational drug use. METHODS: Clinical pharmacists adopted intervention on perioperative use of antibiotics in May and September of 2011, respectively. 50 medical records of surgical patients were randomly selected quarterly for statistical analysis and evaluation of rationality of antibiotic use in 4 quarters using Guidelines for Clinical Use of Antibacterials as criteria. RESULTS: The intervention resulted in great improvement in perioperative use of antibiotics in that both the rate of perioperative use of antibiotics and the rate of irrational drug use have been significantly reduced. CONCLUSION: After rectification of two times, the perioperative use of antibiotics in hospital has become more and more rational. However, efforts still needed to further standardize and institutionalize the rational use of drugs, so as to reduce patients' burden and reduce the occurrence of bacterial drug resistance.
出处 《中国医院用药评价与分析》 2013年第3期279-282,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 临床药师 围术期 抗菌药物 Ⅰ类切口 药学干预 Clinical pharmacist Peroperative period Antimicrobial agents Type I incision Pharmaceutical intervention
  • 相关文献

参考文献4

二级参考文献15

  • 1缪晓辉.抗菌药物临床应用中的问题与对策[J].中华医院管理杂志,2005,21(2):122-125. 被引量:91
  • 2褚桂芬,杨应杰,张永凤,陈映缄,杨丽珍.循证评价妇产科围手术期预防性应用抗生素的现状[J].中国现代医学杂志,2006,16(22):3500-3501. 被引量:14
  • 3余自成(编译),曹久发,张永信(点评.耐药革兰阴性菌感染治疗的药效学指导原则[J].世界临床药物,2007,28(8):454-458. 被引量:10
  • 4Auerbach AD. Prevention of surgical site infections[EB/OL]. http://www. ahrq. gov/ clinic/ ptsafety/ pdf/ ptsafety. pdf.Accessed 8 December 2003.
  • 5Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project[J]. Clin Infect Dis,2004, 38: 1706-1715.
  • 6Page CP,Bohnen JM,Fletcher JR,et al. Antimicrobiai prophylaxis for surgical wounds. Guidelines for clinical care[J].Arch Surg, 1993,128: 79-88.
  • 7Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance[J]. Circulation, 2000,101 : 2916-2921.
  • 8No authers listed. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery American Society of HealthSystem Pharmacists[J]. Am J Health Syst Pharm, 1999,56 :1839-1888.
  • 9Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee [J]. Infect Control Hosp Epidemiol, 1999, 20: 250-278.
  • 10Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections[J]. J Thorac Cardiovasc Surg, 2002,123: 326-332.

共引文献929

同被引文献96

  • 1卫生部办公厅关于抗菌药物临床应用管理有关问题的通知(卫办医政发〔2009〕38号)[J].中华人民共和国卫生部公报,2009(6):43-45. 被引量:44
  • 2李静,卜晓珍.2012-2013年我院抗菌药物使用情况分析[J].农垦医学,2014,36(1):72-75. 被引量:1
  • 3<应用抗菌药物防治外科感染的指导意见>撰写协作组.应用抗菌药物防治外科感染的指导意见(草案)ⅩⅦ——骨和关节感染[J].中华外科杂志,2005,43(4):270-272. 被引量:42
  • 4卫生部办公厅关于做好全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2011]56号.2011.
  • 5卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发[2009]38号.2009.
  • 6卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S],卫医发[2004]285号.2004,8.19.
  • 7卫生部.抗菌药物临床应用管理办法[S].2012,卫生部令84号.
  • 8卫生部.卫生部办公厅关于继续深入开展全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2012]32号,2012-03-05.
  • 9Kuo CY, Su LH, Prerere J, et al. Antimicrobial susceptibility ofShigella isolates in eight Asian countries, 2001-2004. MicrobiolImmunol Infect, 2008, 41(2):107-111.
  • 10Jones RN, Glick T,Sader HS, et al. Educational antimicrobialsusceptibility testing as a critical component of microbiologylaboratory proficiency programs: American Proficiency Instituteresults for 2007-2011. Diagn Microbiol Infect Dis, 2013, 75(4):357-360.

引证文献13

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部